Phase IV, open-label, multicentre trial of afatinib in patients (pts) aged ≥70 yrs with NSCLC harbouring common (Del19/L858R) EGFR mutations: Preliminary results

Phase IV, open-label, multicentre trial of afatinib in patients (pts) aged ≥70 yrs with NSCLC harbouring common (Del19/L858R) EGFR mutations: Preliminary results

Saved in:
Bibliographic Details
Published in:Annals of oncology Vol. 29; p. viii527
Main Authors: Reckamp, K.L., Gilman, P., Halmos, B., Jahanzeb, M., McCann, J., Paripati, H., Seneviratne, L.C., Wallace, J.A., Rueter, B., Esler, A., Dowling, E., Koczywas, M.
Format: Journal Article
Language:English
Published: England Elsevier Ltd 01-10-2018
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
ISSN:0923-7534
1569-8041
DOI:10.1093/annonc/mdy292.078